Perioperative Medicine Beyond Cardiac Clearance Pamela Pride MD July 31, 2012 MUSC.

Slides:



Advertisements
Similar presentations
Evidence-Based Management of Anticoagulant Therapy
Advertisements

Hollie Shaner-McRae DNP RN FAAN
Treatment of Acute Pulmonary Embolism
2012 CHEST Guideline Update VTE prophylaxis, DVT treatment, and Atrial Fibrillation LT Tabatha Welker, PharmD Pharmacy Resident, PHS Claremore Indian Hospital.
Question: How should we manage periprocedural anticoagulation? Paper: Management of Antithrombotic Therapy in Patients Undergoing Invasive Procedures Todd.
Chapter Six Venous Disease Coalition Acute Management of VTE VTE Toolkit.
VTE in abdominal-pelvic surgery patients
DVT PROPHYLAXIS SUNDIP PATEL 7 / 15 / BACKGROUND Deep Vein Thrombosis is a common, yet preventable peri-operative complication Highest risk in critical.
Venous Thromboembolism Prevention August Venous Thromboembloism Prevention 2 Expected Practice  Assess all patients upon admission to the ICU for.
Prophylaxis of Venous Thromboembolism
Venous thromboembolism –
Venous Thromboembolism
Deep Vein Thrombosis (DVT)
Best Practices in Meeting NPSG 3E-Anticoagulation Requirements MaryAnne Cronin, PharmD Assistant Director of Pharmacy Glen Cove Hospital.
DVT Prophylaxis in Medical Patients Rog Kyle, MD MUSC 6/5/12.
Post OP Glucose Control For Cardiac Surgery The Society of Thoracic Surgeons Workforce guidelines (Lazar, 2009) recommended cardiac surgery patients, with.
CHEST-2012: High Points and Pearls Alan Brush, MD, FACP Chief, Anticoagulation Management Service Harvard Vanguard Medical Associates.
DVT/VTE Nursing Protocol (Deep Vein Thrombosis) (Venous Thromboembolism) Presented by Maribeth Desiongco MA, RN-BC 2008.
DVT Prophylaxis in Orthopedic Patients Rogers Kyle, MD Medical University of South Carolina 11/27/12.
LIFEBLOOD THE Thrombosis CHARITY Venous thromboembolism – Treatment and secondary prevention Ulcus cruris Chronic PE PE DVT Post-thrombotic syndrome Death.
Surgery with a Prosthetic Valve- What about the Warfarin? COPYRIGHT © 2014, ALL RIGHTS RESERVED From the Publishers of.
Medical Patients – VTE Prevention Dale W. Bratzler, DO, MPH Professor and Associate Dean, College of Public Health Professor of Medicine, College of Medicine.
DVT Prophylaxis in Orthopedic Patients Rogers Kyle 11/27/12.
Supervisor: Vs 余垣斌 Presenter: CR 周益聖. INTRODUCTION.
Peri-operative management of anticoagulation Marc Carrier MD, MSc FRCPC Assistant Professor, University of Ottawa Associate Scientist, Ottawa Health Research.
PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM
Prevention Of Venous Thromboembolism In The Cancer Surgical Patient A K Kakkar Barts and the London School of Medicine and Thrombosis Research Institute,
Perioperative Medicine Beyond Cardiac Clearance Pamela Pride MD July 31, 2012 MUSC.
Anticoagulation Transitions: Perioperative Care Alan Brush, MD, FACP Clinical Co-Director, Anticoagulation Management Service Harvard Vanguard Medical.
Risk assessment for VTE
Prevention of Venous Thromboembolism 8 th ACCP Guidelines Chest 2008.
Surgical Care Improvement Project Prevention of Post-operative Venous Thromboembolism Team Membership Department of Surgery, Nursing, General Medicine,
VTE Prevention In Action Interactive Case Scenarios.
ANTI-COAGULATION. ENOXAPARIN DOSING Obesity (BMI >= 40 kg/m2) – may increase prophylactic dose by 30% such as in bariatric surgery Abdominal Surgery ….
Venous Thromboembolism Prophylaxis for Medical Inpatients Heather Hofmann, rev. 4/18/14 DSR2 Mini Lecture.
Cost-Consciousness Assignment Ollie Ross DSR 2. Adherence to ACP DVT prophylaxis guidelines Objective: Evaluate adherence to ACP DVT prophylaxis guidelines.
Surgical Care Improvement Project Prevention of Post-operative Venous Thromboembolism Team Membership Department of Surgery, Nursing, General Medicine,
Risk Assessment for VTE. Which of the following best describes you?
Prophylaxis Diagnosis Treatment Venous Thromboembolism Management.
Peri-Operative anticoagulation /antiplatelet therapy A Shift in Paradigm BMHGT04/29/09.
Perioperative Medicine Beyond Cardiac Clearance Pamela Pride MD July 31, 2012 MUSC.
ANTI-COAGULATION. ENOXAPARIN DOSING Obesity (BMI >= 40 kg/m2) – may increase prophylactic dose by 30% such as in bariatric surgery Abdominal Surgery ….
Venous Thromboembolism (VTE) Prophylaxis at Cesarean Section Phillip N. Rauk, MD.
Antithrombotic Therapy for VTE: CHEST Guidelines 2016
Antithrombotic and Thrombolytic Therapy for Valvular Disease Copyright: American College of Chest Physicians 2012 © Antithrombotic Therapy and Prevention.
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke Antithrombotic Therapy and Prevention of Thrombosis: ACCP Evidence-Based Clinical Practice.
Prevention of Venous Thromboembolism in Nonsurgical Patients Copyright: American College of Chest Physicians 2012 © Antithrombotic Therapy and Prevention.
Treatment and Prevention of Heparin- Induced Thrombocytopenia Copyright: American College of Chest Physicians 2012 © Antithrombotic Therapy and Prevention.
Conclusions Results Methods Background Venous thrombo-embolism in patients undergoing neo- adjuvant chemotherapy and surgery for oesophago-gastric cancer.
Prevention of Venous Thromboembolism in Orthopedic Surgery Patients Copyright: American College of Chest Physicians 2012 © Antithrombotic Therapy.
Treatment of deep venous thrombosis and pulmonary embolism Anders Waage.
Antithrombotic and Thrombolytic Therapy for Valvular Disease Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest.
Prevention of Venous Thromboembolism in Nonsurgical Patients Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest.
Spotlight Case January 2006 An Ounce of Prevention.
Outpatient DVT assessment & treatment Daniel Gilada.
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation NEJM Aug 27, 2015.
Introduction - Perioperative management of patients on warfarin or antiplatelet therapy involves assessing and balancing individual risks for thromboembolism.
Low Procedural Bleed Risk
Venous Thromboembolism Prophylaxis for Medical Inpatients
Evidence-Based Management of Anticoagulant Therapy
Treatment and Prevention of Heparin-Induced Thrombocytopenia
Ortho Warfarin Dosing Protocol
Prevention of Venous Thromboembolism in Orthopedic Surgery Patients
Anticoagulation Prepared by Cherie Gan.
Prevention and Management of Venous Thromboembolic Events in Patients With Multiple Myeloma.
Caprini venous thromboembolism risk assessment permits selection for postdischarge prophylactic anticoagulation in patients with resectable lung cancer 
Use of Mifepristone for Prevention of Adrenal Insufficiency Following
by Alex C. Spyropoulos, and James D. Douketis
Thrombophilia in pregnancy: Whom to screen, when to treat
Prevention and Management of Venous Thromboembolic Events in Patients With Multiple Myeloma.
Presentation transcript:

Perioperative Medicine Beyond Cardiac Clearance Pamela Pride MD July 31, 2012 MUSC

Objectives Define the management of anticoagulation List the VTE risk factors List the modes of prophylaxis Differentiate stress dose steroids Identify causes and management of postoperative fever

Key Messages Patients on chronic anticoagulation with high risk of thrombosis should be bridged preoperatively with short acting anticoagulation (i.e. heparin gtt or enoxaparin) Recommending LMWH for post op DVT prophylaxis is rarely incorrect. Recommendations regarding stress dose steroids for patients on chronic glucocorticoids are available, although data supporting their routine use is lacking. Fevers in the first 48 hours post op are common and routine work up with chest xray, blood and urine cultures is not indicated in an otherwise asymptomatic patient.

Perioperative Medicine Beyond Cardiac Clearance Management of anticoagulation Management of anticoagulation VTE prophylaxis VTE prophylaxis Stress dose steroids Stress dose steroids Postoperative fever Postoperative fever

Antiplatelet Therapy and Surgery

Anticoagulation and Surgery

To bridge or not bridge Bridge Dual prosthetic or old valve Dual prosthetic or old valve VTE w/in 3 months VTE w/in 3 months Pregnancy and PV Pregnancy and PV PV with embolism in past 6 months PV with embolism in past 6 months Afib with chad score ≥ 5 Afib with chad score ≥ 5 Bileaflet valve with additional risk factors Bileaflet valve with additional risk factors Don’t Bridge Bileaflet AV VTE >12 months ago Afib with chad score ≤ 2 and no hx of cva/tia

Venous Thromboembolism Prophylaxis VTE Risk Factors Surgery Surgery Trauma Trauma Immobility Immobility Malignancy Malignancy Hx of VTE Hx of VTE Advanced age Advanced age Pregnancy/HRT Pregnancy/HRT Organ failure Organ failure IBD IBD Nephrotic syndrome Myeolproliferative d/o PNH Obesity Tobacco abuse Varicose veins CV catheters Thrombophilia

Modes Of Prophylaxis LDUH LDUH LMWH LMWH ASA ASA Coumadin Coumadin GCS GCS Foot pumpers Fondaparinux Early mobilization IPC IVC filter

VTE Prophylaxis Made Easy “KISS” Recommend LMWH unless risk of bleeding is high, then use mechanical prophylaxis However…………….

VTE Prophylaxis Special Circumstances  Warfarin vs. LMWH vs. fondaparinux  How long to treat?  Hips  Knees  Bariatric surgery  Renal insufficiency  HIT

Adrenal Physiology Baseline daily cortisol secretion 8-10mg Baseline daily cortisol secretion 8-10mg Surgical stress increases baseline secretion Surgical stress increases baseline secretion Exogenous steroids inhibit CRH and ACTH secretion Exogenous steroids inhibit CRH and ACTH secretion Adrenal atrophy may result and blunt normal response Adrenal atrophy may result and blunt normal response

Who is at risk for HPA suppression? Assume suppression Greater than 20mg/d prednisone for more than 3 weeks Greater than 20mg/d prednisone for more than 3 weeks Clinically Cushingoid Clinically Cushingoid Assume No Suppression Any dose for less than 3 weeks Less than 5mg/d prednisone for any duration Alternate day regimen

Stress Dose Steroids Minor surgical stress Minor surgical stress Take usual morning dose Take usual morning dose Moderate surgical stress Moderate surgical stress Take usual morning dose plus 50mg IV HCT prior to surgery and 25mg IV q8hours for 3 doses Take usual morning dose plus 50mg IV HCT prior to surgery and 25mg IV q8hours for 3 doses Major surgical stress Major surgical stress Take usual am dose plus 100mg IV HCT prior to surgery and 50mg IV q8 for 3 doses, then taper by 50% each day Take usual am dose plus 100mg IV HCT prior to surgery and 50mg IV q8 for 3 doses, then taper by 50% each day

What does the data show? Data limited by few RCTs and low sample sizes Data limited by few RCTs and low sample sizes 1-2% incidence of adrenal insufficiency when steroids completely withheld 1-2% incidence of adrenal insufficiency when steroids completely withheld No difference between stress dose and maintenance dose No difference between stress dose and maintenance dose Patients with adrenal crisis respond to “rescue” stress dose steroids Patients with adrenal crisis respond to “rescue” stress dose steroids

Surgical Patients on Chronic Steroids-Summary Post op adrenal insufficiency is a rare but serious complication Post op adrenal insufficiency is a rare but serious complication With holding steroids completely leads to higher rates of crisis With holding steroids completely leads to higher rates of crisis Data suggests that maintenance dosing with close post-op monitoring is advisable Data suggests that maintenance dosing with close post-op monitoring is advisable If decision is made to give stress dose steroids, follow previous listed recs If decision is made to give stress dose steroids, follow previous listed recs

Postoperative Fever Common, related to cytokines Common, related to cytokines History and physical exam only recommended for first 48 hours postop History and physical exam only recommended for first 48 hours postop

References Vinik R, et al. Periprocedural antithrombotic management:A review of the literature and practical approach for the hospitalist physician. J Hosp Med 4(9) November 2009 Vinik R, et al. Periprocedural antithrombotic management:A review of the literature and practical approach for the hospitalist physician. J Hosp Med 4(9) November 2009 Guyatt, G, et al. Antithrombotic Therapy and Prevention of Thombosis 9 th Ed: ACCP Guidelines. Chest November 2012 Issue 2 Supplement Guyatt, G, et al. Antithrombotic Therapy and Prevention of Thombosis 9 th Ed: ACCP Guidelines. Chest November 2012 Issue 2 Supplement Badillo A, Sarani B, and S Evans. Optimizing Use of Blood Cultures in the Febrile Postoperative patient. J Am Coll Surg 194(4): Badillo A, Sarani B, and S Evans. Optimizing Use of Blood Cultures in the Febrile Postoperative patient. J Am Coll Surg 194(4): Axelrod L. Perioperative Management of Patients treated with glucocorticoids. Endocrinol Metab Clin North Am. June 32(2)367: Axelrod L. Perioperative Management of Patients treated with glucocorticoids. Endocrinol Metab Clin North Am. June 32(2)367: